BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30246385)

  • 1. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
    Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
    Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
    Vajtai I; Vassella E; Hewer E; Kappeler A; Reinert MM
    Pathol Res Pract; 2012 Dec; 208(12):750-5. PubMed ID: 23102810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted.
    Yasuda T; Nitta M; Komori T; Kobayashi T; Masui K; Maruyama T; Sawada T; Muragaki Y; Kawamata T
    Neuropathology; 2018 Feb; 38(1):41-46. PubMed ID: 28812310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
    Hiniker A; Hagenkord JM; Powers MP; Aghi MK; Prados MD; Perry A
    Clin Neuropathol; 2013; 32(3):165-70. PubMed ID: 23254140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histological characteristics of recurrent oligodendroglial tumors: comparison between primary and recurrent tumors in 18 cases.
    Kanamori M; Kumabe T; Shibahara I; Saito R; Yamashita Y; Sonoda Y; Suzuki H; Watanabe M; Tominaga T
    Brain Tumor Pathol; 2013 Jul; 30(3):151-9. PubMed ID: 23053495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoma-like tumor originating from oligodendroglioma.
    Shoji T; Saito R; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
    Brain Tumor Pathol; 2016 Oct; 33(4):255-260. PubMed ID: 27333891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligosarcomas, IDH-mutant are distinct and aggressive.
    Suwala AK; Felix M; Friedel D; Stichel D; Schrimpf D; Hinz F; Hewer E; Schweizer L; Dohmen H; Pohl U; Staszewski O; Korshunov A; Stein M; Wongsurawat T; Cheunsuacchon P; Sathornsumetee S; Koelsche C; Turner C; Le Rhun E; Mühlebner A; Schucht P; Özduman K; Ono T; Shimizu H; Prinz M; Acker T; Herold-Mende C; Kessler T; Wick W; Capper D; Wesseling P; Sahm F; von Deimling A; Hartmann C; Reuss DE
    Acta Neuropathol; 2022 Feb; 143(2):263-281. PubMed ID: 34967922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent oligodendroglioma with changed 1p/19q status.
    Barresi V; Mafficini A; Calicchia M; Piredda ML; Musumeci A; Ghimenton C; Scarpa A
    Neuropathology; 2022 Apr; 42(2):160-166. PubMed ID: 35144313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma.
    Sathornsumetee S; Cheunsuchon P; Sangruchi T
    World Neurosurg; 2016 Jul; 91():518-523.e1. PubMed ID: 26960282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components.
    Hattab EM; Martin SE; Shapiro SA; Cheng L
    J Neurosurg; 2011 Jun; 114(6):1648-53. PubMed ID: 21214337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
    Hacisalihoglu P; Kucukodaci Z; Gundogdu G; Bilgic B
    Turk Neurosurg; 2017; 27(5):682-689. PubMed ID: 27651340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy.
    Hata N; Shono T; Mizoguchi M; Matsumoto K; Guan Y; Nagata S; Hayashi K; Iwaki T; Sasaki T
    Neurol Res; 2007 Oct; 29(7):723-6. PubMed ID: 17553214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An IDH1-mutated primary gliosarcoma: case report.
    Hsieh JK; Hong CS; Manjila S; Cohen ML; Lo S; Rogers L; Sloan AE
    J Neurosurg; 2017 Feb; 126(2):476-480. PubMed ID: 27153165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment.
    Higuchi F; Uzuka T; Matsuda H; Sumi T; Iwata K; Namatame T; Shin M; Akutsu H; Ueki K
    Brain Tumor Pathol; 2024 Apr; 41(2):80-84. PubMed ID: 38294664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative molecular analysis of primary and recurrent oligodendroglioma that acquired imbalanced 1p/19q codeletion and TP53 mutation: a case report.
    Ono T; Reinhardt A; Takahashi M; Nanjo H; Kamataki A; von Deimling A; Shimizu H
    Acta Neurochir (Wien); 2020 Dec; 162(12):3019-3024. PubMed ID: 32785787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.
    Murakami C; Ikota H; Nobusawa S; Nakata S; Yamazaki T; Hashiba Y; Hirato J; Yokoo H
    Pathol Int; 2020 Jan; 70(1):40-46. PubMed ID: 31855307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of chromosome 1p and 19q status and expression of R132H mutant IDH1 protein in oligodendroglial tumors].
    Yao K; Duan Z; Hu Z; Bian Y; Qi X
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):663-7. PubMed ID: 25567591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.